Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Hematology Drugs Market Briefing 2017-2022 - Research and Markets

Research and Markets
Posted on: 03 Jan 18

The "Hematology Drugs Market Global Briefing 2017" report has been added to Research and Markets' offering.

The global hematology drugs market is expected to reach around $45 billion in 2020.

Hematology drugs market offers drugs, blood and blood products that are used for the treatment of diseases such as rare genetic disorders, anemia, and conditions related to sickle cell disease and other related diseases. Some of the major hematology drugs include Albumin, Epoetin, Zoladex, and Hyskon.

Going forward, unhealthy lifestyle leading to anemia and coagulation disorders, along with increased longevity and the launch of pipeline drugs is set to drive the market for hematology drugs.

Tranexamic Acid To Prevent Postpartum Hemorrhage - Tranexamic acid is increasingly being used to prevent postpartum hemorrhage (blood loss of over 500 ml or 1,000 ml within 24 hours of childbirth) due to its cheap price and wide availability. Tranexamic acid is an antifibrinolytic drug that helps in reducing bleeding in surgical and trauma patients, including women with postpartum hemorrhage.

In April 2017, WOMAN (World Maternal Antifibrinolytic), an international, randomized, double-blind, placebo-controlled trial including over 20,000 women from 193 hospitals in 21 countries, found that using tranexamic acid within three hours of childbirth lowered death from bleeding by 31% and reduced the need for laparotomy (emergency bleeding control surgery) by 36%, as compared to placebo.


  • Markets Covered: Blood Products, Anemia And Other Blood Disorder Drugs.
  • Time Series: Five years historic and forecast.
  • Data: Market value in $ billions.
  • Data Segmentations: Regional breakdowns, market share of competitors, key sub segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

  • Novo Nordisk A/S
  • Shire Plc.
  • Bayer AG
  • Daiichi Sankyo Company
  • Biogen Inc.
  • Pfizer Inc.

For more information about this report visit

View source version on

Business Wire

Last updated on: 03/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.